St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Destiny Hinton
Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.
Stories by Destiny Hinton
Will Mother Nature deal a deadly hand with influenza virus?
How close are we to another deadly influenza virus pandemic? Read about how scientists are figuring out how to prevent the next catastrophe.
St. Jude community partnership highlighted during World AIDS Day
Read how St. Jude is reaching out to youth for HIV education and prevention, including a clinical trial for an HIV prevention and treatment drug.
Chronic pain in survivors: How we can better understand an under-studied problem
A new model explains key factors in chronic pain development, and future pain research designed to answer overlooked questions
Targeted therapy larotrectinib could make tumors with rare NTRK fusion genes less lethal
Newly approved Vitrakvi (larotrectinib) scored high patient response rates by inhibiting a rare chromosomal abnormality that drives tumor growth.
What is extreme phenotype sequencing? Taking STEPS to improve genome-wide association studies
Will a new genome sequencing data mining technique reveal the mother lode of secrets for treating cancer and other catastrophic diseases?
St. Jude and WHO collaborate to improve cancer cure rate
Learn how St. Jude and World Health Organization are taking on the six most common childhood cancers to improve global survival rates.
What is causing resistance to the new flu drug, Xofluza?
A recently discovered mutation that occurs when the flu virus is exposed Xofluza could also cause drug resistance.
You can help prevent suicide
Suicidal thoughts or actions are not the end – don’t believe these myths associated with suicide.
NLRP3 balance: St. Jude researchers pinpoint key innate immune system regulator
For 12 years, science didn’t know how certain immune responses were activated. They do now, and it may lead to new cancer treatments.
What you’re missing if you’re only sequencing exomes or RNA
New findings from St. Jude study Genomes 4 Kids suggest many actionable mutations are missed without a three-platform genomic sequencing approach that includes WGS.